{
    "items": [
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/981646\" title=\"Detection of Clinically Relevant Molecular Alterations in Chronic Lymphocytic Leukemia (CLL) By Nanopore Sequencing\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/981646/@@modal\" class=\"state-synced\">Detection of Clinically Relevant Molecular Alterations in Chronic Lymphocytic Leukemia (CLL) By Nanopore Sequencing</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/982250\" title=\"Ibrutinib Plus Venetoclax in Relapsed/Refractory CLL: Results of the Bloodwise TAP Clarity Study\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/982250/@@modal\" class=\"state-synced\">Ibrutinib Plus Venetoclax in Relapsed/Refractory CLL: Results of the Bloodwise TAP Clarity Study</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/542695\" title=\"Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/542695/@@modal\" class=\"state-synced\">Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/1004721\" title=\"A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/1004721/@@modal\" class=\"state-synced\">A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/991092\" title=\"Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/991092/@@modal\" class=\"state-synced\">Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/585944\" title=\"Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/585944/@@modal\" class=\"state-synced\">Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/718758\" title=\"EARLY LESSONS FROM WHOLE-GENOME SEQUENCING IN THE CLINICAL DIAGNOSIS OF RARE INHERITED ANAEMIAS\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/718758/@@modal\" class=\"state-synced\">EARLY LESSONS FROM WHOLE-GENOME SEQUENCING IN THE CLINICAL DIAGNOSIS OF RARE INHERITED ANAEMIAS</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/717121\" title=\"IDENTIFICATION OF ABERRANTLY SPLICED GENES AND DEREGULATED PATHWAYS/GENE ONTOLOGY THEMES IN MYELODYSPLASTIC SYNDROME PATIENTS WITH SPLICING FACTOR GENE MUTATIONS\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/717121/@@modal\" class=\"state-synced\">IDENTIFICATION OF ABERRANTLY SPLICED GENES AND DEREGULATED PATHWAYS/GENE ONTOLOGY THEMES IN MYELODYSPLASTIC SYNDROME PATIENTS WITH SPLICING FACTOR GENE MUTATIONS</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/718947\" title=\"CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPRESSING THE LIGHT CHAIN IGLV3-21 HAVE A POOR PROGNOSIS INDEPENDENTLY OF HEAVY CHAIN IGHV3-21 OR THE IGHV MUTATIONAL STATUS\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/718947/@@modal\" class=\"state-synced\">CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPRESSING THE LIGHT CHAIN IGLV3-21 HAVE A POOR PROGNOSIS INDEPENDENTLY OF HEAVY CHAIN IGHV3-21 OR THE IGHV MUTATIONAL STATUS</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/718948\" title=\"A NOVEL TELOMERASE RNA COMPONENT VARIANT IN A FAMILY WITH MACROCYTOSIS AND MILD VARIABLE CYTOPENIAS\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/718948/@@modal\" class=\"state-synced\">A NOVEL TELOMERASE RNA COMPONENT VARIANT IN A FAMILY WITH MACROCYTOSIS AND MILD VARIABLE CYTOPENIAS</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/718957\" title=\"THE INITIAL REPORT OF THE BLOODWISE TAP CLARITY STUDY COMBINING IBRUTINIB AND VENETOCLAX IN RELAPSED, REFRACTORY CLL SHOWS ACCEPTABLE SAFETY AND PROMISING EARLY INDICATIONS OF EFFICACY\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/718957/@@modal\" class=\"state-synced\">THE INITIAL REPORT OF THE BLOODWISE TAP CLARITY STUDY COMBINING IBRUTINIB AND VENETOCLAX IN RELAPSED, REFRACTORY CLL SHOWS ACCEPTABLE SAFETY AND PROMISING EARLY INDICATIONS OF EFFICACY</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/612188\" title=\"Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/612188/@@modal\" class=\"state-synced\">Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/66877\" title=\"Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/66877/@@modal\" class=\"state-synced\">Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/859197\" title=\"Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/859197/@@modal\" class=\"state-synced\">Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/1003186\" title=\"The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/1003186/@@modal\" class=\"state-synced\">The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/930009\" title=\"Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/930009/@@modal\" class=\"state-synced\">Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/542177\" title=\"A phase 3, randomized, double-blind, placebo-controlled study evaluating the efFicacy and safely or idelalisib (GS-1101) in combination with bendamustine and Minimal) for previously treated chronic lymphocytic leukemia (CLL).\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/542177/@@modal\" class=\"state-synced\">A phase 3, randomized, double-blind, placebo-controlled study evaluating the efFicacy and safely or idelalisib (GS-1101) in combination with bendamustine and Minimal) for previously treated chronic lymphocytic leukemia (CLL).</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/543012\" title=\"Phase 3 study of oral lenalidomide as maintenance therapy for patients with B-cell chronic lyouphocylic leukemia (CLL).\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/543012/@@modal\" class=\"state-synced\">Phase 3 study of oral lenalidomide as maintenance therapy for patients with B-cell chronic lyouphocylic leukemia (CLL).</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/470708\" title=\"Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/470708/@@modal\" class=\"state-synced\">Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://oxplored.oncology.ox.ac.uk/publications/470551\" title=\"DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://oxplored.oncology.ox.ac.uk/publications/470551/@@modal\" class=\"state-synced\">DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma</a>\n                </h2>\n  \n                \n\n                \n                \n                \n                        \n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n"
    ], 
    "more": "\n\n    \n        <a href=\"https://oxplored.oncology.ox.ac.uk/publications?7bcae41c-05d7-11ee-8005-061b866677b4=&amp;random=3193afd6-72de-45db-80eb-92082dbd336b&amp;b_start:int=140&amp;format=json\" title=\"Load more\" class=\"btn btn-default load-more-button\">\n            Load More\n        </a>\n    \n\n", 
    "msg": ""
}